Conference Presentation, Fireside Chat, Panel
Jack Andraka Talks About the Bioscience Discovery Process at Milken Institute Global Conference
- Jack Andraka (2012 Intel Science Fair Grand Prize winner and Baltimore-based student) developed a novel diagnostic method for pancreatic, ovarian, and lung cancer at age 16, inspired by the death of a family friend from pancreatic cancer at age 13.
- Current Diagnostic Limitations: The existing standard of care is over 60 years old, costs $800 per test, misses 30% of cancer cases, and results in 85% of pancreatic cancers being diagnosed too late, leaving patients with less than a 2% survival rate.
- Andraka's Prototype Specifications:
- Cost: $0.03 per test.
- Speed: Results available in five minutes.
- Sensitivity: 100% accurate in clinical trials to date.
- Early Detection: Capable of identifying cancer at the earliest stage, when survival rates approach 100%.
- Performance Metrics: The sensor is 168 times faster, 26,000 times less expensive, and over 400 times more sensitive than the current medical standard.
- Scientific Methodology:
- Andraka utilized freely available online databases to analyze over 8,000 blood proteins, eventually identifying mesothelin as a reliable biomarker for the target cancers; this protein appears at high levels even in early-stage disease.
- He engineered the sensor using single-walled carbon nanotubes (microscopic carbon pipes 150,000 times thinner than human hair) woven with antibodies designed to react exclusively with mesothelin.
- Production Process: A simple, low-tech method involving mixing water, carbon nanotubes, and antibodies, dipping a piece of paper, and drying it (compared by Andraka to making chocolate chip cookies).
- Research Obstacles & Validation:
- Andraka was initially denied access to professional labs; he emailed 200 professors at Johns Hopkins University and the NIH with his proposal, receiving 199 rejections and harsh technical critiques.
- Only one professor agreed to a trial, subjecting Andraka to a rigorous "interrogation" in a room packed with 20+ PhDs; despite guessing answers to complex technical questions (analogous to SAT guessing), he successfully demonstrated his procedure.
- After seven months of lab work, the prototype successfully detected the target cancers with the reported accuracy.
- Forward-Looking Statements & Scalability:
- The technology is adaptable; by swapping the specific antibody, the sensor platform can potentially detect HIV/AIDS, Alzheimer's, heart disease, and other forms of cancer.
- The low cost and simplicity suggest high scalability for global health applications compared to current expensive diagnostic infrastructure.
- Family Dynamics & Education:
- Andraka's parents fostered curiosity by engaging him in inquiry-based learning, often answering his questions with counter-questions rather than direct answers.
- Early scientific interest began at age three through physics experiments with a toy river model and continued through diverse hobbies, including kayaking, sports, and music (trombone), before he settled on science.
- His first formal science fair project was completed in sixth grade, marking a sustained trajectory of scientific engagement.